BSECompany Update16 Sept 2026 · 16 Sept 2026, 04:12 pm

Intimation about Schedule of Analyst / Institutional Investor Meeting on September 23 - 25, 2026

Neuland Laboratories Ltd · 524558

✦ AI Summary

Neuland Laboratories Ltd has announced its participation in a group analyst/institutional investor meeting from September 23-25, 2026, in Singapore.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

9dcf77fd-1a38-4a7a-a189-549201210711.pdf

pdf

Download →
View document text
September 16, 2026 BSE Limited The National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, 25th Floor, Exchange Plaza, Dalal Street, Mumbai – 400 001 Bandra Kurla Complex Bandra (E), Mumbai – 400 001 Scrip Code: 524558 Scrip Code: NEULANDLAB; Series: EQ Dear Sir/Madam, Sub: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings This is to inform you that the Company’s management will be participating in the following group analyst/ investor meeting(s): Date Name of the Analyst / Location Nature of the Institutional Investor / Event meeting September 23 - 25, Goldman Sachs Global Singapore Group meet / 2026 Healthcare CDMO Day One-on-One meet Please note that the schedule & participant list of the aforesaid meeting(s) is subject to change due to any exigencies on the part of Participants / Company. This is for your information and records. Thanking you Yours Sincerely, For Neuland Laboratories Limited Sarada Bhamidipati Company Secretary